Lighting is often the last thing cultivators budget for, and one of the biggest levers for profitability. In this episode of The Cultivator's Edge, host Tim Gordon talks with Mikail Segal, CEO of TSR Grow, and Zach Taylor, Head of Cultivation at Bountiful Farms, about how centralized, data-driven lighting is changing what's possible in commercial cultivation, from cutting energy costs to boosting rosin yield.Panelists:- Mikail Segal, CEO, TSR Grow- Zach Taylor, Head of Cultivation, Bountiful Farms3 top takeaways:1. Crop-steer your lighting like you crop-steer fertigation: By centralizing drivers and ballasts away from the fixtures, TSR Grow's platform lets cultivators build and repeat precise lighting "recipes" for each strain, rather than applying one law-of-averages setting across an entire room.2. The right spectrum can move the needle on your most valuable metric: Zach shares that under-canopy lighting boosted plant mass while cutting labor hours, and dialing in far-red spectrum pushed rosin yield up as much as 1%, a small-sounding number with outsized ROI at commercial scale.3. AI is a tool, not a decision-maker: Both guests are clear that AI is powerful for spotting patterns, compiling data, and reducing risk (like auto-dimming lights when HVAC systems are stressed), but the "art" of cultivation, and the final call, still belongs to the grower.The conversation also digs into why lighting, HVAC, and fertigation all need to "talk" to each other for a system to actually work, how tightening margins are forcing cultivators to optimize for efficiency rather than just maximum production, and why building a data-backed growing "recipe" is becoming essential as global compliance standards like GACP demand documented consistency.Part of The Cultivator's Edge, a GCNC WorldView content series.

THC and CBD built the cannabis industry, but the real frontier might be everything else in the plant. In this episode of The Cultivator's Edge, we examine the race to unlock CBG, CBC, and THCV for pharmaceutical use, and why THC might be the one thing standing in the way.

Panelists:

• Gustavo Escobar, CEO, Clever Leaves
• Nisha Whiteley, COO, Credo Science

3 top takeaways:

1. Non-psychoactive cannabinoids open doors THC keeps shut, especially in pharmaceutical markets like Brazil and Europe.
2. Supply is still the industry's biggest bottleneck, and it's harder to solve than you'd think.
3. High THC was never a quality signal. The industry taught the market to believe it was, and it's time to unlearn it.

Also inside: Colombia's brutal genetics import gauntlet, an ALS drug in active development, and why real pharmaceutical-grade cannabis is a decade-long bet few are willing to make.

Part of The Cultivator's Edge, a GCNC WorldView content series.

Scaling a cannabis operation internationally is easy to get wrong — and expensive to fix once it breaks. In this episode of The Cultivator's Edge, hosts Wally Daniel and Tim Gordon sit down with Cory Drippon (Garden Gems Drop N Grow) and Ash Ganley (Cannabis Global Consultants) to talk through what actually holds up when cultivation operations grow from one room to many.

3 top takeaways:

1) Scale in modular units, not undifferentiated space. Instead of treating a large facility as one big domain, build it from repeatable, self-contained units (like standardized 16-light rooms) using identical equipment and digitized SOPs that replicate cleanly room to room.

2) Updating craft experience with repeatable process. Oral history and artisanal methods don't scale. Data-driven, professional SOPs keep quality consistent even when training local talent with no prior cannabis experience.

3) Size your HVAC and dehumidification for the plant load — and keep humans out of the room. Properly sized environmental systems and minimized human interaction are two of the most effective safeguards against microbial risk as you grow.

The conversation also digs into the real difference between GACP (cultivation) and EU-GMP (post-harvest processing); why they demand fundamentally different infrastructure, hygiene protocols, and business models; and, where the panel sees the industry heading next, as advanced environmental control tech gets applied beyond cannabis to other high-value medicinal and nutraceutical plants.

Part of The Cultivator's Edge, a GCNC WorldView content series.

The economics of cannabis cultivation keep shifting, and last year's smart decision can quietly become this year's costly mistake. In this episode of The Cultivator's Edge (GCNC WorldView), host Tim Gordon and a panel of cultivation experts break down the real, often expensive lessons learned building and scaling facilities — from HVAC and financial modeling to genetics, AI, and surviving price compression.Panelists:Wally Daniel, Green Garden ConsultingDaniel Craveiro, Camaraderie TechnologyGabriel Londono, Harbor House Collective3 Top Takeaways:1) Match your systems to your actual goal: Size your HVAC, controls, and infrastructure to your real end product — under- or over-building both lead to expensive do-overs.2) Don't let data lag blind your decisions: Slow feedback loops mean you're planting your next crops "blindly" before you've learned from the last one.3) Review your P&L with the whole team. Getting owners, investors, and staff in the same room surfaces the unused subscriptions and unnecessary costs nobody's watching.Part of The Cultivator's Edge, a GCNC WorldView content series.

How do you evolve an industry icon? In this episode of GCNC WorldView, we go behind the scenes with Emily Standbrook and Kate Holste to explore the strategic transformation of Boveda’s cannabis line into its new identity: Vivi.

In this episode:

-- Sales & Marketing Handshake: A rebrand lives or dies by the alignment of these two departments. TK and YK explain how they bridged the gap between creative vision and bottom-line reality to ensure Vivi hit the shelves with momentum.

-- Re-Education: Strategies for pivoting a loyal audience toward a new brand identity without losing legacy trust.

-- Global Playbooks: Navigating the complexities of brand presence across diverse international markets and shifting regulations.

Welcome the GCNC Worldview’s Cannabis By The Numbers podcast series: in partnership with Whitney Economics and Verdant Strategies: two leading international cannabis business consultancies.In this final episode, the trio have a frank and insightful discussion about the current US and international cannabis markets, pondering what rescheduling means, and what the knock on effects will be.Tune in to hear more about:

• How regulators need to step up
• The challenges facing US cannabis operators in a national and international marketplace
• Why some operators are discussing acquisition ahead of rescheduling
• Standardisation and quality control

#podcast #cannabis #business #economics #finance #hemp

Welcome the GCNC Worldview’s Cannabis By The Numbers podcast series: in partnership with Whitney Economics and Verdant Strategies: two leading international cannabis business consultancies.

In this episode, Chris Day, co-founder, GCNC, Beau Whitney from Whitney Economics, and Rachel Wright from Verdant Strategies dive into a lively discussion surrounding how different stakeholders perceive risk – and what that means for your cannabusiness.

Tune in to hear more about:

- Bankers vs. investors vs. operators: risk perspectives
- The role of compliance, reporting, and perception
- The shrinking pool of cannabis-friendly financial institutions
- Building a risk-ready business in a high-stakes environment

#podcast #cannabis #business #economics #finance #hemp

It’s tough times for many out there; but for those working in cannabis, the challenges can feel magnified.In this episode, Beau, Rachel, and Chris discuss ways to mitigate what seems to be an accounts receivable crisis in this nascent industry and how to avoid collapse through better fundamentals. Tune in to hear more about:

• Economic trends: declining licenses, increasing closures
• Rachel’s turnaround strategies and governance audits
• Foundational business practices that prevent litigation
• A survival guide for cannabis operators under pressure

#podcast #cannabis #business #economics #finance #hemp

Amid all of the noise around the U.S.’ intoxicating hemp ban, in this episode of Cannabis By The Numbers, Chris, Rachel, and Beau, explore industrial hemp’s economic promise and political neglect, and ask: how does that affect scalability?They discuss:- Global hemp supply chains - Opportunities in Europe, South America, Africa, and the U.S.- The USDA’s data gap- What’s holding back investment and adoption?- Reframing sectors as a scalable, high-impact commodity. Tune in to find out more!#podcast #cannabis #business #economics #finance #hemp

Welcome the GCNC Worldview’s Cannabis By The Numbers podcast series: in partnership with Whitney Economics and Verdant Strategies: two leading international cannabis business consultancies.In this eight-episode series, Chris Day, co-founder, GCNC will look at the cannabis industry from a data and finance perspective, alongside international cannabis economist, Beau Whitney, from Whitney Economics; and finance and accounting expert, Rachel Wright from Verdant Strategies.This week we’ll be examining the economic and business implications of cannabinoid regulation, including: - State-level bans and their ripple effects- Survey data on cannabinoid impact- How entrepreneurs can pivot in fragmented policy environments- Spotlighting emerging cannabinoids and market volatility#podcast #cannabis #business #economics #finance #hemp